Clearance Summary
EROS-CLITORAL THERAPY DEVICE (CTD) received FDA 510(k) clearance under submission number DEN000006, sponsored by Urometrics, Inc.. The device was reviewed via the Post-NSE premarket notification pathway and assigned to the Obstetrics/Gynecology review panel. The statutory decision date of record is 2000-04-28.
- Submission: DEN000006
- Applicant / Sponsor: Urometrics, Inc.
- Clearance pathway: Post-NSE
- Review panel: Obstetrics/Gynecology
- Device class: Class II
- Regulation citation: 21 CFR 884.5970
- Decision date: 2000-04-28
Classification & Regulation
This clearance is catalogued under FDA product code NBV and 21 CFR 884.5970, within the Obstetrics/Gynecology review panel as a Class II device.